State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
Background The incidence of secondary pulmonary infections is not well described in
hospitalized COVID-19 patients. Understanding the incidence of secondary pulmonary …
hospitalized COVID-19 patients. Understanding the incidence of secondary pulmonary …
A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)
Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
Some patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
develop severe pneumonia and acute respiratory distress syndrome (ARDS). Distinct …
develop severe pneumonia and acute respiratory distress syndrome (ARDS). Distinct …
Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia
CO Pickens, CA Gao, MJ Cuttica, SB Smith… - American journal of …, 2021 - atsjournals.org
Rationale: Current guidelines recommend patients with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pneumonia receive empirical antibiotics for suspected …
coronavirus 2 (SARS-CoV-2) pneumonia receive empirical antibiotics for suspected …
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
PE Verweij, RJM Brüggemann, E Azoulay… - Intensive care …, 2021 - Springer
Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and …
Summary COVID-19-associated pulmonary mucormycosis (CAPM) remains an
underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus …
underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus …
Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19
BACKGROUND Despite guidelines promoting the prevention and aggressive treatment of
ventilator-associated pneumonia (VAP), the importance of VAP as a driver of outcomes in …
ventilator-associated pneumonia (VAP), the importance of VAP as a driver of outcomes in …
Distinctive features of severe SARS-CoV-2 pneumonia
The coronavirus disease 2019 (COVID-19) pandemic is among the most important public
health crises of our generation. Despite the promise of prevention offered by effective …
health crises of our generation. Despite the promise of prevention offered by effective …
What does 95% COVID-19 vaccine efficacy really mean?
P Olliaro - The Lancet Infectious Diseases, 2021 - thelancet.com
It is imperative to dispel any ambiguity about how vaccine efficacy shown in trials translates
into protecting individuals and populations. The mRNA-based Pfizer1, 2 and Moderna3 …
into protecting individuals and populations. The mRNA-based Pfizer1, 2 and Moderna3 …
Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?
Background Pneumocystis jirovecii (P. jirovecii) is increasingly identified on lower
respiratory tract specimens of COVID-19 patients. Our narrative review aims to determine …
respiratory tract specimens of COVID-19 patients. Our narrative review aims to determine …